chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, Pancreatic carcinoma, SARS-CoV-2 test positive, Stent placement, Vaccination failure
Clinical narrative: Narrative: 66yo male patient in hospice care at home died at home on 1/9/2022. Pt w/ hx of pancreatic CA s/p palliative rad and getting chemo - recent ERCP w/ stent replacement, COPD, CAD, DVT's and PE's, EtOH and PSA. Pt had received covid vaccines on 2/14/21 & 3/13/21. Pt was found to be covid positive on 12/13/2021 (day of ERCP) Pt seen in ER on 12/20/21 for lightheadedness post ERCP procedure. Pt decided to transfer to hospice after discharged from Er on 12/20/21. Since pt decided to go to hospice, he did not get monoclonal immunotherapy for covid + infection in the ER. Not clear if pt died of untreated covid infection or from cancer (or both). Pt had 2 doses of covid vaccine early in 2021 revealing failure to provide immunity from infection, as expected by now. Problem list: Seen by palliative care medicine service Primary malignant neoplasm of head of pancreas (SCT 372119009) Chronic obstructive lung disease (SCT 13Long-term current use of insulin (SCT 710815001) Chronic neck pain (SCT1121000119107) Coronary atherosclerosis (SCT 443502000) Neoplasm of uncertain behavior of left uChronic pain syndrome (SCT 373621006) History of bilateral total knee replacemDeep venous thrombosis (SCT 12805330) Anticoagulant effect (SCT 10191004) Benign prostatic hyperplasia (SCT 266569009) Contusion of hip (SCT 44801007) Restless legs syndrome (SCT 32914008) Pancreatitis (ICD-9-CM 577.0) Impotence, Organic Origin (ICD-9-CM 607.84) Osteoarthritis (SCT 396275006) L/T (CURRENT) USE0ANTICOAG (IICD-9-CM V58.61) Tobacco use (SCT 110483000) Depression (SCT 35489007) Caffeine-Induced Anxiety Disorder (ICD-9Alcohol Abuse (ICD-9-CM 305.00) Cannabis abuse, episodic use (ICD-9-CM 3Generalized anxiety disorder (SCT 21897009) Adj Reac W/Mixed Emotion (ICD-9-CM 309.2Cocaine Depend, Episodic (ICD-9-CM 304.22) Degeneration of lumbar intervertebral diOsteroarthrosis involving the knee (ICD-9-CM 715.98) Varicose Veins (ICD-9-CM 454.90 Hip Pain (ICD-9-CM 719.45) Benign essential hypertension (SCT 1010Diabetes mellitus SCT 73211009) Hyperlipidemia (SCT 55822004) Personal History of Venous Thrombosis and Embolism (ICD-9-CM V12.51) Other Pulmonary Embolism and Infarction Gastroesophageal reflux disease (SCT 235595009) Chronic Low Back Pain (ICD-9-CM 724.2) Osteoarthritis of knee (SCT 239873007) Colon Polyp (ICD-9-CM 211.3) Mood Disorder (ICD-9-CM 296.90)
Age: 89.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative:  80yo male Pt died on 12/7/2021. Pt had received covid vaccines at nonresident site on 2/18/21 & 3/11/21. Pt had moved into assisted living facility where got a new PCP. Last facility chart note on 8/18/2021. Pt died of unknown cause, unknown location & unknown circumstances. Facilities problem list:  PROBLE LAST MOD PROVIDER Essential Hypertension (SCT 1201005) (ICD-10-CM 07/06/2016 I10) Chronic Kidney Disease, Unspecified (SCT 07/06/2016 42399005) (ICD-10-CM-N18.9) Abdominal aneurysm without mention of rupture 02/12/2014 (ICD-9-CM 441.4) Other and unspecified hyperlipidemia (SCT 07/06/2016 267434003) (ICD-10-CM E78.2) Peripheral Vascular Disease, Unspecified 02/12/2014 (ICD-9-CM 443.9) Coronary Atherosclerosis (unspecified type 07/06/2016 vessel, native or graft) (SCT 53741008) (ICD-10-CM I25.10) Sensorineural Hearing Loss (SCT 161451004) (ICD-10-CM M10.9) 07/06/2016 Personal History of other Mental Disorders 02/12/2014 (ICD-9-CM V11.8) Chronic airway obstruction, Not Elsewhere 07/06/2016 Classified (SCT 13645005) (ICD- 10-CM J44.9) Personal History of Tobacco Use (SCT 07/06/2016 1221000119103) (ICD-10-CM Z87.891) Diabetes Mellitus without mention of 07/06/2016 Complication, type II or  unspecified type, not stated as Uncontrolled (SCT 313436004) (ICD-10-CM E11.9) This death is likely not related to the vaccinations due to patient's  comorbidities, advanced age, and length of time from vaccine administration.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Arterial occlusive disease, Cardio-respiratory arrest, Central venous catheter removal, Death, Haemoptysis
Clinical narrative: Narrative:  67yo male pt died in the ER at hospital after coding on 12/14/2021. Death was caused by: cardiopulm arrest, nsc lung cancer, arterial occlucion. HX: tob abuse,severe copd, htn,chf, cabg,cva- local hospital, metastatic lung adenocarcinoma recent hemoptysis, (cancer workup has not been completed, chemo/RT not started), picc line right upper extremity recently removed. Pt had received covid vaccines on 4/5/21 & 3/8/21. This death is not related to covid vaccines.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Non-small cell lung cancer
Clinical narrative: Narrative:  67yo male pt died in the ER at hospital after coding on 12/14/2021. Death was caused by: cardiopulm arrest, nsc lung cancer, arterial occlucion. HX: tob abuse,severe copd, htn,chf, cabg,cva- local hospital, metastatic lung adenocarcinoma recent hemoptysis, (cancer workup has not been completed, chemo/RT not started), picc line right upper extremity recently removed. Pt had received covid vaccines on 4/5/21 & 3/8/21. This death is not related to covid vaccines.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Death, Inappropriate schedule of product administration
Clinical narrative: Narrative: 61 yo male patient who received covid vaccine on 3/31/21 & 4/30/21 died of unknown causes, unknown location & unknown circumstances on 12/22/2021. It appears pt stopped coming to Facility on 4/30/2021. No notes since that date. PROMBLEM LIST: Other chronic nonalcoholic liver diseasehypertension, Essential Osteoarthritis (ICD-9-CM 715.90) Tinnitus (ICD-9-CM 388.30) Unspecified sinusitis (chronic) (ICD-9-CPainic Disorder without Agoraphobia (IDC-9-CM 300.01) HYPERLIPIDEMIA Unable to assess if this death is related to covid vaccines. Likely death is not given long timer period between date of vaccines and date of death.
Age: 73.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Hypoaesthesia oral, Impaired healing, Lip exfoliation, Pruritus, Rash pruritic
Clinical narrative: Received Pfizer vaccine (dose 1) on 3/19/21. Patient called a PCP on 4/5/21 stating he brought a sleeping cushion upstairs from basement and began to get "little bumps that were very itchy" after sleeping on it on 3/19/21. Thought it could be bedbugs. He had not seen any bedbugs and had no prior history of them in his home. Received second doe of Pfizer vaccine 4/16/21. Per physician note on 1/6/21: severe reaction pfizer covid vaccine (severe puritis. skin got raw, lost skin palms, lips, legs now scarred. Numbness in lower lip (finally resolved); occured after first dose. Has slow healing sore since first dose. Has slow healing sore since first shot in March, left calf area.
Age: 73.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Scar, Skin erosion, Skin exfoliation
Clinical narrative: Received Pfizer vaccine (dose 1) on 3/19/21. Patient called a PCP on 4/5/21 stating he brought a sleeping cushion upstairs from basement and began to get "little bumps that were very itchy" after sleeping on it on 3/19/21. Thought it could be bedbugs. He had not seen any bedbugs and had no prior history of them in his home. Received second doe of Pfizer vaccine 4/16/21. Per physician note on 1/6/21: severe reaction pfizer covid vaccine (severe puritis. skin got raw, lost skin palms, lips, legs now scarred. Numbness in lower lip (finally resolved); occured after first dose. Has slow healing sore since first dose. Has slow healing sore since first shot in March, left calf area.
Age: 94.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Blood creatinine increased, COVID-19, Diarrhoea, Dysstasia
Clinical narrative: Narrative:  93 year old male with underlying dementia and a Slums score of 1 as of July 1st 2021 present to facility for worsening weakness and diarrhea for at least 4 weeks per patient's daughter. Patient is unable to participate in the HPI due to underlying cognitive status. The daughter endorses that the patient is unable to answer questions very well at baseline and there has been no worsening mental changes prior to admission. Per the daughter patient has been getting progressively weaker over the last few days. At baseline he is able to use a walker but today she endorses that he is unable to sit errect on the commode and is unable to stand up using a walker or hold on to the wall during ambulation which prompted her to call EMS. Upon work up patient was noted to have covid 19 on respiratory biofire. Per the daughter patient had no respiratory symtpoms. He was brought to the ED approximately one month ago and was negative. He has been fully vaccinated for this but has not yet recieved a booster. Also upon workup patient's creatinine was noted to be 1.5. He has underlying CKD but presenting renal function is elevated from baseline. admit for further review
Age: 94.0
Sex: M
Vaccine: COVID19
Symptoms: Gait disturbance, Posture abnormal, Renal impairment, Respiratory viral panel, SARS-CoV-2 test positive
Clinical narrative: Narrative:  93 year old male with underlying dementia and a Slums score of 1 as of July 1st 2021 present to facility for worsening weakness and diarrhea for at least 4 weeks per patient's daughter. Patient is unable to participate in the HPI due to underlying cognitive status. The daughter endorses that the patient is unable to answer questions very well at baseline and there has been no worsening mental changes prior to admission. Per the daughter patient has been getting progressively weaker over the last few days. At baseline he is able to use a walker but today she endorses that he is unable to sit errect on the commode and is unable to stand up using a walker or hold on to the wall during ambulation which prompted her to call EMS. Upon work up patient was noted to have covid 19 on respiratory biofire. Per the daughter patient had no respiratory symtpoms. He was brought to the ED approximately one month ago and was negative. He has been fully vaccinated for this but has not yet recieved a booster. Also upon workup patient's creatinine was noted to be 1.5. He has underlying CKD but presenting renal function is elevated from baseline. admit for further review
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Anal incontinence, COVID-19, COVID-19 pneumonia, Chest X-ray abnormal, Dyspnoea
Clinical narrative: Narrative:  Per Asdmission HPI pt"...is a 62 y/o male who presented to the ED today via caregiver from the group home where he resides for shortness of breath, defecating on himself and increase in urination that is not normal for him. Patient has had a TBI and resides in group home where there have been positive Covid 19 cases... denies any complaints of pain and reports feeling tired. He is non toxic in appearance with 2L o2 via nasal cannula and o2 sat is 100%. He was found to be hypoxic with ambulation and he tested positive for Covid 19. He will be admitted for Covid 19 pneumonia, hypoxemia and hypernatremia. Patient discharged 1/10/22
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Exposure to SARS-CoV-2, Fatigue, Hypernatraemia, Hypoxia, Lung infiltration
Clinical narrative: Narrative:  Per Asdmission HPI pt"...is a 62 y/o male who presented to the ED today via caregiver from the group home where he resides for shortness of breath, defecating on himself and increase in urination that is not normal for him. Patient has had a TBI and resides in group home where there have been positive Covid 19 cases... denies any complaints of pain and reports feeling tired. He is non toxic in appearance with 2L o2 via nasal cannula and o2 sat is 100%. He was found to be hypoxic with ambulation and he tested positive for Covid 19. He will be admitted for Covid 19 pneumonia, hypoxemia and hypernatremia. Patient discharged 1/10/22
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Pollakiuria, Pulmonary mass, Pulmonary oedema, SARS-CoV-2 test positive
Clinical narrative: Narrative:  Per Asdmission HPI pt"...is a 62 y/o male who presented to the ED today via caregiver from the group home where he resides for shortness of breath, defecating on himself and increase in urination that is not normal for him. Patient has had a TBI and resides in group home where there have been positive Covid 19 cases... denies any complaints of pain and reports feeling tired. He is non toxic in appearance with 2L o2 via nasal cannula and o2 sat is 100%. He was found to be hypoxic with ambulation and he tested positive for Covid 19. He will be admitted for Covid 19 pneumonia, hypoxemia and hypernatremia. Patient discharged 1/10/22
Age: 91.0
Sex: M
Vaccine: COVID19
Symptoms: Death, Dementia
Clinical narrative: Narrative: 90yo male patient died during inpatient hospice care on 1/8/2022. Death was cause by: End stage dementia POA. Pt had received 3 covid vaccines on 1/15/21, 2/13/21, & 11/18/2021. This death is not related to covid vaccinations.
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: Death, Inappropriate schedule of product administration
Clinical narrative: Narrative: 85yo male patient with NSCLC (lung cancer) in home hospice care died at home on 1/3/2022. Pt had received covid vaccines on 2/4/21 & 3/8/21. This death is not related to covid vaccines.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Chronic obstructive pulmonary disease, Death, Essential hypertension, Hypertension, Insomnia
Clinical narrative: Narrative: 71yo female patient with the following problem list. PROBLEM LAST MOD PROVIDER Hypertensive disorder (ICD-10-CM 01/27/2016 I10) Peripheral vascular disease, unspecified (ICD-10-CM I73.9); Peripheral vascular disease Essential (primary) Hypertension 03/27/2018 (ICD-10-CM I10); Benign essential hypertension Chronic obstructive pulmonary disease, 03/14/2017 unspecified (ICD-10-CM J44.9); Chronic obstructive lung disease Other seizures (ICD-10-CM 03/14/2017 G40.89); Seizure Neurotic Depression (ICD-9-CM 300.4); Dysthymia 11/06/2002 Insomnia nec (ICD-9-CM 780.52) Pt received covid vaccines at non facility site on 2/4/21 & 3/4/21. Pt died on 12/31/2021. Not able to assess if covid vaccines were related to pt's death.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral vascular disorder, Persistent depressive disorder, Seizure
Clinical narrative: Narrative: 71yo female patient with the following problem list. PROBLEM LAST MOD PROVIDER Hypertensive disorder (ICD-10-CM 01/27/2016 I10) Peripheral vascular disease, unspecified (ICD-10-CM I73.9); Peripheral vascular disease Essential (primary) Hypertension 03/27/2018 (ICD-10-CM I10); Benign essential hypertension Chronic obstructive pulmonary disease, 03/14/2017 unspecified (ICD-10-CM J44.9); Chronic obstructive lung disease Other seizures (ICD-10-CM 03/14/2017 G40.89); Seizure Neurotic Depression (ICD-9-CM 300.4); Dysthymia 11/06/2002 Insomnia nec (ICD-9-CM 780.52) Pt received covid vaccines at non facility site on 2/4/21 & 3/4/21. Pt died on 12/31/2021. Not able to assess if covid vaccines were related to pt's death.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative: 82yo female patient with end-stage renal disease & Heart failure actively dying when signed up for care. Pt had received covid vaccines on 2/8/21 & 3/12/21 from non facility site. Pt died on 12/26/2021. This death is likely not related to the vaccinations due to patient's comorbidities, advanced age, and length of time from vaccine administration.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Narrative
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Inappropriate schedule of product administration, SARS-CoV-2 test positive
Clinical narrative: Narrative:
Age: 93.0
Sex: F
Vaccine: COVID19
Symptoms: Cerebrovascular accident, Computerised tomogram head abnormal, Drooling, Dysphagia, Fluid intake reduced
Clinical narrative: Narrative:  Patient developed stroke like symptoms 1 day s/p Janssen vaccine 2nd dose administration including incoherent speech, drooling, inability to drink fluids. She was transported to local ER, CT + for stroke and airlifted to trauma level 1 hospital. She currently remains in neuro ICU there.
Age: 93.0
Sex: F
Vaccine: COVID19
Symptoms: Incoherent, Intensive care, Neurological symptom
Clinical narrative: Narrative:  Patient developed stroke like symptoms 1 day s/p Janssen vaccine 2nd dose administration including incoherent speech, drooling, inability to drink fluids. She was transported to local ER, CT + for stroke and airlifted to trauma level 1 hospital. She currently remains in neuro ICU there.
Age: 93.0
Sex: F
Vaccine: COVID19
Symptoms: Cerebrovascular accident, Computerised tomogram abnormal, Dysphagia, Speech disorder
Clinical narrative: Narrative:  The patient was noted to have impaired speech and difficulty swallowing on the morning of 12/14/21. She was at baseline when she went to bed the evening prior. She was transported to Hospital. A CT scan showed a CVA. The patient was then transported to Medical Center for a higher level of care.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Chest pain, Chills, Headache, Injection site pain
Clinical narrative: First 48 hours included body aches, headache, chills, feverish, sore arm at injection site. Abdominal pain  existed, chest pain. 1 week later abdominal pain, chest pain still exists, similar to acid reflex or heartburn. Insomnia as pain persists at night.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Insomnia, Pain, Pyrexia
Clinical narrative: First 48 hours included body aches, headache, chills, feverish, sore arm at injection site. Abdominal pain  existed, chest pain. 1 week later abdominal pain, chest pain still exists, similar to acid reflex or heartburn. Insomnia as pain persists at night.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Joint swelling, Swelling face, Vision blurred
Clinical narrative: This spontaneous case was reported by an other health care professional and describes the occurrence of SWELLING FACE (Temples swollen), JOINT SWELLING (Ankles swollen), VISION BLURRED (Blurred vision) and HEADACHE (Intermittent headache) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 058S21A, 027A21A and 012M21A) for COVID-19 vaccination.     The patient's past medical history included Ex-smoker (She quit smoking couple years ago.). Concurrent medical conditions included Allergy to antibiotic (Severe allergy to amoxicillin 12 months ago). Concomitant products included ASCORBIC ACID (VITAMIN-C) and VITAMIN D [VITAMIN D NOS] for an unknown indication.   On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 11-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced SWELLING FACE (Temples swollen), JOINT SWELLING (Ankles swollen), VISION BLURRED (Blurred vision) and HEADACHE (Intermittent headache). The patient was treated with DEXAMETHASONE for Temple swelling and Ankles swollen, at an unspecified dose and frequency; FUROSEMIDE (LASIX [FUROSEMIDE]) for Temple swelling and Ankles swollen, at an unspecified dose and frequency and IBUPROFEN at an unspecified dose and frequency. At the time of the report, SWELLING FACE (Temples swollen), JOINT SWELLING (Ankles swollen), VISION BLURRED (Blurred vision) and HEADACHE (Intermittent headache) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Since patient quit smoking patient never had swelling in patients life.   This case was linked to MOD-2022-452018, MOD-2022-452561, MOD-2022-452546 (Patient Link).
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site rash, Insomnia, Pruritus, Rash, Skin warm
Clinical narrative: Pt presented to urgent care 3/29/21 with complaint of rash x 10 days. Pt states she received her first dose of Moderna vaccine on 3/17 (12 days ago). Two days later pt broke out in a rash at the site of the injection on her left arm, which spread across her chest/abdomen/back/groin/right arm. Pt reports she has been using OTC steroid and benadryl creams without relief. Pt describes the rash as "hot" and "extremely itchy." Pt states she has not been able to sleep at all since start of the rash. Pt saw her PCP 4 days ago who prescribed Atarax, which pt stopped using due to no relief. Pt states her PCP recommended oral steroids as next step, but pt was unable to get in to see them today. Pt denies fever or any purulent drainage from the rash. Pt given rx for prednisone 14 day taper.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Anticoagulant therapy, Jugular vein thrombosis, Subclavian artery thrombosis, Venous thrombosis limb
Clinical narrative: Blood clots in internal jugularvein, subclavian vein and 4 major veins in left arm down to wrist. In hospital from 04/12/2021 to 04/162021 and again from 04/17/2021 to 04/24/2021. treated with heparin drip both admission and discharged on Coumadin until 10/27/2021.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Feeling abnormal, Syncope, Vaginal haemorrhage
Clinical narrative: c/o feeling fuzzy headed and lightheaded. States she fainted a couple of days after the vaccine but has a HX of fainting (complete workup for fainting with no identified cause). Also c/o bright red vaginal spotting 2 days after receiving the vaccine which is alarming to member since she's been in official menopause for over two years.
Age: 50.0
Sex: F
Vaccine: VARZOS
Symptoms: Pain, Rash
Clinical narrative: Presented to clinic with complaints of reaction to Shingrix injection.  Patient received injection 3/3/2021 in right arm.  Patient had complaints of soreness and then awoke 3/7/2021 with rash.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Alopecia
Clinical narrative: Systemic: hair loss-Mild
Age: 21.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Chest pain, Dyspnoea, Echocardiogram, Ejection fraction abnormal, Electrocardiogram normal
Clinical narrative: Systemic: Cardiac Disorder (diagnosed by MD)-Severe, Additional Details: myocarditis
Age: 21.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Myocarditis, Troponin increased
Clinical narrative: Systemic: Cardiac Disorder (diagnosed by MD)-Severe, Additional Details: myocarditis
Age: 21.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Myocarditis
Clinical narrative: Systemic: Cardiac Disorder (diagnosed by MD)-Severe, Additional Details: myocarditis
Age: 21.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Cardiac disorder, Myocarditis
Clinical narrative: Systemic: Cardiac Disorder (diagnosed by MD)-Severe, Additional Details: myocarditis
Age: 10.0
Sex: M
Vaccine: UNK, COVID19
Symptoms: Loss of consciousness
Clinical narrative: Site: Pain at Injection Site-Mild, Systemic: PRE-SYNCOPAL EVENT FOR 30 MINS-Mild, Systemic: Flushed / Sweating-Mild, Systemic: Hypotension-Mild, Systemic: Visual Changes/Disturbances-Mild
Age: 10.0
Sex: M
Vaccine: UNK, COVID19
Symptoms: Flushing, Hyperhidrosis, Hypotension, Injection site pain, Presyncope
Clinical narrative: Site: Pain at Injection Site-Mild, Systemic: PRE-SYNCOPAL EVENT FOR 30 MINS-Mild, Systemic: Flushed / Sweating-Mild, Systemic: Hypotension-Mild, Systemic: Visual Changes/Disturbances-Mild
Age: 10.0
Sex: M
Vaccine: UNK, COVID19
Symptoms: Visual impairment
Clinical narrative: Site: Pain at Injection Site-Mild, Systemic: PRE-SYNCOPAL EVENT FOR 30 MINS-Mild, Systemic: Flushed / Sweating-Mild, Systemic: Hypotension-Mild, Systemic: Visual Changes/Disturbances-Mild
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Feeling cold, Immunisation, Interchange of vaccine products, Off label use
Clinical narrative: DID HAVE A REACTION; FEELING EXTREMELY COLD; This spontaneous report received from a patient concerned a male of unspecified age race and ethnicity. The patient's height, and weight were not reported. The patient's concurrent conditions included: ulcer, anemia, and lower back issue. The patient received covid-19 vaccine ad26.cov2.s (dose number in series:1) (suspension for injection, intramuscular, batch number: UNKNOWN) dose was not reported, 1 total administered on 18-MAY-2021 for prophylactic vaccination. The batch number was not reported and has been requested. On an unspecified date (after J&J vaccine), the patient did have a reaction (adverse event) which lasted almost 2 months.(dose number in series:1) Non-company suspect vaccine included: bnt 162 (dose number in series:2) (form of admin, route of admin, and batch number were not reported) dose was not reported, 1 total booster dose administered on 14-DEC-2021 for an unspecified indication. No concomitant medications were reported. Starting on 28-DEC-2021, the patient was feeling cold. At the time of report, the patient was feeling extremely cold even though being fully dressed (dose number in series:2). The action taken with covid-19 vaccine ad26.cov2.s, and bnt 162 was not applicable. The patient recovered from did have a reaction, and had not recovered from feeling extremely cold. This report was non-serious.; Sender's Comments: V0: Medical assessment comment not required as per standard procedure as the case is assessed as non serious.
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Adverse event, Feeling cold
Clinical narrative: DID HAVE A REACTION; FEELING EXTREMELY COLD; This spontaneous report received from a patient concerned a male of unspecified age race and ethnicity. The patient's height, and weight were not reported. The patient's concurrent conditions included: ulcer, anemia, and lower back issue. The patient received covid-19 vaccine ad26.cov2.s (dose number in series:1) (suspension for injection, intramuscular, batch number: UNKNOWN) dose was not reported, 1 total administered on 18-MAY-2021 for prophylactic vaccination. The batch number was not reported and has been requested. On an unspecified date (after J&J vaccine), the patient did have a reaction (adverse event) which lasted almost 2 months.(dose number in series:1) Non-company suspect vaccine included: bnt 162 (dose number in series:2) (form of admin, route of admin, and batch number were not reported) dose was not reported, 1 total booster dose administered on 14-DEC-2021 for an unspecified indication. No concomitant medications were reported. Starting on 28-DEC-2021, the patient was feeling cold. At the time of report, the patient was feeling extremely cold even though being fully dressed (dose number in series:2). The action taken with covid-19 vaccine ad26.cov2.s, and bnt 162 was not applicable. The patient recovered from did have a reaction, and had not recovered from feeling extremely cold. This report was non-serious.; Sender's Comments: V0: Medical assessment comment not required as per standard procedure as the case is assessed as non serious.
Age: 15.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Blood pressure increased, Dyspnoea, Electrocardiogram normal, Hypoaesthesia, Seizure
Clinical narrative: Systemic: Dizziness / Lightheadness-Severe, Systemic: Fainting / Unresponsive-Mild, Systemic: Flushed / Sweating-Mild, Systemic: Hypotension-Mild, Systemic: Nausea-Mild, Systemic: Shakiness-Medium
Age: 15.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Abdominal discomfort, Dyspnoea, Seizure
Clinical narrative: Systemic: Dizziness / Lightheadness-Severe, Systemic: Fainting / Unresponsive-Mild, Systemic: Flushed / Sweating-Mild, Systemic: Hypotension-Mild, Systemic: Nausea-Mild, Systemic: Shakiness-Medium
Age: 15.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Dizziness, Flushing, Hyperhidrosis, Hypotension, Nausea
Clinical narrative: Systemic: Dizziness / Lightheadness-Severe, Systemic: Fainting / Unresponsive-Mild, Systemic: Flushed / Sweating-Mild, Systemic: Hypotension-Mild, Systemic: Nausea-Mild, Systemic: Shakiness-Medium
Age: 15.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Syncope, Tremor, Unresponsive to stimuli
Clinical narrative: Systemic: Dizziness / Lightheadness-Severe, Systemic: Fainting / Unresponsive-Mild, Systemic: Flushed / Sweating-Mild, Systemic: Hypotension-Mild, Systemic: Nausea-Mild, Systemic: Shakiness-Medium
Age: 24.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Muscle tightness, Myalgia, Oedema peripheral, Pain in extremity
Clinical narrative: Systemic: Joint Pain-Mild, Systemic: Lymph Node Swelling-Severe, Systemic: Tingling (specify: facial area, extemities)-Medium
Age: 24.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Arthralgia, Lymphadenopathy, Paraesthesia
Clinical narrative: Systemic: Joint Pain-Mild, Systemic: Lymph Node Swelling-Severe, Systemic: Tingling (specify: facial area, extemities)-Medium
Age: 24.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Muscle swelling, Muscle tightness, Myalgia, Pain in extremity, Peripheral swelling
Clinical narrative: Systemic: Joint Pain-Mild, Systemic: Lymph Node Swelling-Severe, Systemic: Tingling (specify: facial area, extemities)-Medium
Age: 37.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: ADMINISTRATION OF VACCINE WHICH WAS STORED OUTSIDE OF THE ACCEPTABLE LIMITS; ADMINISTRATION ERROR/INCORRECTLY STORED VACCINE ADMINISTERED; This spontaneous report received from a physician concerned a 37 year old male. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 213D21A, expiry: 11-APR-2022) dose was not reported, administered on 04-DEC-2021 13:38 for prophylactic vaccination. No concomitant medications were reported. On 04-DEC-2021, the patient experienced administration error/incorrectly stored vaccine administered. On an unspecified date, the patient experienced administration of vaccine which was stored outside of the acceptable limits.  The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the administration error/incorrectly stored vaccine administered and administration of vaccine which was stored outside of the acceptable limits was not reported. This report was non-serious. This case, from the same reporter is linked to 20220124475 and 20220123990.
Age: 37.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Poor quality product administered, Product storage error
Clinical narrative: ADMINISTRATION OF VACCINE WHICH WAS STORED OUTSIDE OF THE ACCEPTABLE LIMITS; ADMINISTRATION ERROR/INCORRECTLY STORED VACCINE ADMINISTERED; This spontaneous report received from a physician concerned a 37 year old male. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 213D21A, expiry: 11-APR-2022) dose was not reported, administered on 04-DEC-2021 13:38 for prophylactic vaccination. No concomitant medications were reported. On 04-DEC-2021, the patient experienced administration error/incorrectly stored vaccine administered. On an unspecified date, the patient experienced administration of vaccine which was stored outside of the acceptable limits.  The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the administration error/incorrectly stored vaccine administered and administration of vaccine which was stored outside of the acceptable limits was not reported. This report was non-serious. This case, from the same reporter is linked to 20220124475 and 20220123990.
Age: 57.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: ADMINISTRATION OF VACCINE WHICH WAS STORED OUTSIDE OF THE ACCEPTABLE LIMITS; ADMINISTRATION ERROR/INCORRECTLY STORED VACCINE ADMINISTERED; This spontaneous report received from a physician concerned a 57 year old female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 213D21A, and expiry: 11-APR-2022) dose was not reported, administered on 09-JAN-2022 14:09 for prophylactic vaccination. No concomitant medications were reported.  On 09-JAN-2022, the patient experienced administration error/incorrectly stored vaccine administered. On an unspecified date, the patient experienced administration of vaccine which was stored outside of the acceptable limits. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the administration error/incorrectly stored vaccine administered and administration of vaccine which was stored outside of the acceptable limits was not reported. This report was non-serious. This case, from the same reporter is linked to 20220123990 and 20220124443.
Age: 57.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Poor quality product administered, Product storage error
Clinical narrative: ADMINISTRATION OF VACCINE WHICH WAS STORED OUTSIDE OF THE ACCEPTABLE LIMITS; ADMINISTRATION ERROR/INCORRECTLY STORED VACCINE ADMINISTERED; This spontaneous report received from a physician concerned a 57 year old female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 213D21A, and expiry: 11-APR-2022) dose was not reported, administered on 09-JAN-2022 14:09 for prophylactic vaccination. No concomitant medications were reported.  On 09-JAN-2022, the patient experienced administration error/incorrectly stored vaccine administered. On an unspecified date, the patient experienced administration of vaccine which was stored outside of the acceptable limits. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the administration error/incorrectly stored vaccine administered and administration of vaccine which was stored outside of the acceptable limits was not reported. This report was non-serious. This case, from the same reporter is linked to 20220123990 and 20220124443.
Age: 17.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Muscle disorder, Muscle spasms
Clinical narrative: 2 days after patient received the vaccine she started having spasms which started in her hands. Since then she has continued to have spasm randomly throughout her body. She has not had spasm everyday but has had severe ones that have caused her to fall as part of them.
Age: 17.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Fall, Muscle spasms
Clinical narrative: 2 days after patient received the vaccine she started having spasms which started in her hands. Since then she has continued to have spasm randomly throughout her body. She has not had spasm everyday but has had severe ones that have caused her to fall as part of them.
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Anxiety, Blood test normal, Epistaxis, Insomnia, Nasal cavity packing
Clinical narrative: This spontaneous report received from a patient concerned a 68 year old of unspecified sex. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included: The patient had never had bloody nose, ever in her lifetime. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 05-OCT-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 07-OCT-2021, the patient experienced nosebleed. On an unspecified date, the patient experienced abnormal congestion, inability to breathe, inability to sleep, pressure behind eyes and along bridge of nose, and headache. Treatment medications (dates unspecified) included: benzalkonium chloride/glycine/oxymetazoline hydrochloride/phenylmercuric acetate/sorbitol, and paraffin soft. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from nosebleed on 09-DEC-2021, and had not recovered from abnormal congestion, inability to breathe, inability to sleep, pressure behind eyes and along bridge of nose, and headache. This report was non-serious.
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Nasal congestion, Ocular discomfort, Paranasal sinus discomfort, Pharyngeal haemorrhage, Respiratory tract congestion
Clinical narrative: This spontaneous report received from a patient concerned a 68 year old of unspecified sex. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included: The patient had never had bloody nose, ever in her lifetime. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 05-OCT-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 07-OCT-2021, the patient experienced nosebleed. On an unspecified date, the patient experienced abnormal congestion, inability to breathe, inability to sleep, pressure behind eyes and along bridge of nose, and headache. Treatment medications (dates unspecified) included: benzalkonium chloride/glycine/oxymetazoline hydrochloride/phenylmercuric acetate/sorbitol, and paraffin soft. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from nosebleed on 09-DEC-2021, and had not recovered from abnormal congestion, inability to breathe, inability to sleep, pressure behind eyes and along bridge of nose, and headache. This report was non-serious.
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Upper-airway cough syndrome
Clinical narrative: This spontaneous report received from a patient concerned a 68 year old of unspecified sex. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included: The patient had never had bloody nose, ever in her lifetime. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 05-OCT-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 07-OCT-2021, the patient experienced nosebleed. On an unspecified date, the patient experienced abnormal congestion, inability to breathe, inability to sleep, pressure behind eyes and along bridge of nose, and headache. Treatment medications (dates unspecified) included: benzalkonium chloride/glycine/oxymetazoline hydrochloride/phenylmercuric acetate/sorbitol, and paraffin soft. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from nosebleed on 09-DEC-2021, and had not recovered from abnormal congestion, inability to breathe, inability to sleep, pressure behind eyes and along bridge of nose, and headache. This report was non-serious.
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Dyspnoea, Epistaxis, Headache, Insomnia, Paranasal sinus discomfort
Clinical narrative: This spontaneous report received from a patient concerned a 68 year old of unspecified sex. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included: The patient had never had bloody nose, ever in her lifetime. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 05-OCT-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 07-OCT-2021, the patient experienced nosebleed. On an unspecified date, the patient experienced abnormal congestion, inability to breathe, inability to sleep, pressure behind eyes and along bridge of nose, and headache. Treatment medications (dates unspecified) included: benzalkonium chloride/glycine/oxymetazoline hydrochloride/phenylmercuric acetate/sorbitol, and paraffin soft. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from nosebleed on 09-DEC-2021, and had not recovered from abnormal congestion, inability to breathe, inability to sleep, pressure behind eyes and along bridge of nose, and headache. This report was non-serious.
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Sinus congestion
Clinical narrative: This spontaneous report received from a patient concerned a 68 year old of unspecified sex. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included: The patient had never had bloody nose, ever in her lifetime. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 05-OCT-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 07-OCT-2021, the patient experienced nosebleed. On an unspecified date, the patient experienced abnormal congestion, inability to breathe, inability to sleep, pressure behind eyes and along bridge of nose, and headache. Treatment medications (dates unspecified) included: benzalkonium chloride/glycine/oxymetazoline hydrochloride/phenylmercuric acetate/sorbitol, and paraffin soft. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from nosebleed on 09-DEC-2021, and had not recovered from abnormal congestion, inability to breathe, inability to sleep, pressure behind eyes and along bridge of nose, and headache. This report was non-serious.
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Amnesia, Dizziness, Electrocardiogram normal, Fall, Fatigue
Clinical narrative: Systemic: Fainting / Unresponsive-Medium, Systemic: Vomiting-Mild, Additional Details: PT HAS NOT PAST MEDICAL HISTORY OF ADVERSE EVENT OR SEIZURES BUT INDICATED TO IMMUNIZER NERVOUS ABOUT VACCINE. PT  RECIEVED VACCINE AT 11:02 AM & SAT DOWN FOR MONITORING AT 11:08AM. PT HAD HEAD DOWN & STATED FEELING NAUSEOUS. WATER WAS PROVIDED BUT PT DID NOT CONSUME & WAS NOT RESPONDING TO STAFF. CONFIRMED VIA VIDEO 11:12AM PT JERKED FORWARD & FELL OVER ON HER SIDE. 911 WAS CALLED PT WAS AWAKE BUT NOT ALERT.
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Gait disturbance, Head injury, Headache, Illness, Loss of consciousness
Clinical narrative: Systemic: Fainting / Unresponsive-Medium, Systemic: Vomiting-Mild, Additional Details: PT HAS NOT PAST MEDICAL HISTORY OF ADVERSE EVENT OR SEIZURES BUT INDICATED TO IMMUNIZER NERVOUS ABOUT VACCINE. PT  RECIEVED VACCINE AT 11:02 AM & SAT DOWN FOR MONITORING AT 11:08AM. PT HAD HEAD DOWN & STATED FEELING NAUSEOUS. WATER WAS PROVIDED BUT PT DID NOT CONSUME & WAS NOT RESPONDING TO STAFF. CONFIRMED VIA VIDEO 11:12AM PT JERKED FORWARD & FELL OVER ON HER SIDE. 911 WAS CALLED PT WAS AWAKE BUT NOT ALERT.
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Malaise, Nausea, Somnolence, Vomiting
Clinical narrative: Systemic: Fainting / Unresponsive-Medium, Systemic: Vomiting-Mild, Additional Details: PT HAS NOT PAST MEDICAL HISTORY OF ADVERSE EVENT OR SEIZURES BUT INDICATED TO IMMUNIZER NERVOUS ABOUT VACCINE. PT  RECIEVED VACCINE AT 11:02 AM & SAT DOWN FOR MONITORING AT 11:08AM. PT HAD HEAD DOWN & STATED FEELING NAUSEOUS. WATER WAS PROVIDED BUT PT DID NOT CONSUME & WAS NOT RESPONDING TO STAFF. CONFIRMED VIA VIDEO 11:12AM PT JERKED FORWARD & FELL OVER ON HER SIDE. 911 WAS CALLED PT WAS AWAKE BUT NOT ALERT.
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Depressed level of consciousness, Dyskinesia, Fall, Nausea, Posture abnormal
Clinical narrative: Systemic: Fainting / Unresponsive-Medium, Systemic: Vomiting-Mild, Additional Details: PT HAS NOT PAST MEDICAL HISTORY OF ADVERSE EVENT OR SEIZURES BUT INDICATED TO IMMUNIZER NERVOUS ABOUT VACCINE. PT  RECIEVED VACCINE AT 11:02 AM & SAT DOWN FOR MONITORING AT 11:08AM. PT HAD HEAD DOWN & STATED FEELING NAUSEOUS. WATER WAS PROVIDED BUT PT DID NOT CONSUME & WAS NOT RESPONDING TO STAFF. CONFIRMED VIA VIDEO 11:12AM PT JERKED FORWARD & FELL OVER ON HER SIDE. 911 WAS CALLED PT WAS AWAKE BUT NOT ALERT.
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Syncope, Unresponsive to stimuli, Vomiting
Clinical narrative: Systemic: Fainting / Unresponsive-Medium, Systemic: Vomiting-Mild, Additional Details: PT HAS NOT PAST MEDICAL HISTORY OF ADVERSE EVENT OR SEIZURES BUT INDICATED TO IMMUNIZER NERVOUS ABOUT VACCINE. PT  RECIEVED VACCINE AT 11:02 AM & SAT DOWN FOR MONITORING AT 11:08AM. PT HAD HEAD DOWN & STATED FEELING NAUSEOUS. WATER WAS PROVIDED BUT PT DID NOT CONSUME & WAS NOT RESPONDING TO STAFF. CONFIRMED VIA VIDEO 11:12AM PT JERKED FORWARD & FELL OVER ON HER SIDE. 911 WAS CALLED PT WAS AWAKE BUT NOT ALERT.
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Bradycardia, Flushing, Hyperhidrosis, Hyporesponsive to stimuli, Hypotension
Clinical narrative: Systemic: Fainting / Unresponsive-Medium, Systemic: Vomiting-Mild, Additional Details: PT HAS NOT PAST MEDICAL HISTORY OF ADVERSE EVENT OR SEIZURES BUT INDICATED TO IMMUNIZER NERVOUS ABOUT VACCINE. PT  RECIEVED VACCINE AT 11:02 AM & SAT DOWN FOR MONITORING AT 11:08AM. PT HAD HEAD DOWN & STATED FEELING NAUSEOUS. WATER WAS PROVIDED BUT PT DID NOT CONSUME & WAS NOT RESPONDING TO STAFF. CONFIRMED VIA VIDEO 11:12AM PT JERKED FORWARD & FELL OVER ON HER SIDE. 911 WAS CALLED PT WAS AWAKE BUT NOT ALERT.
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Loss of consciousness, Speech disorder, Syncope, Unresponsive to stimuli
Clinical narrative: Systemic: Fainting / Unresponsive-Medium, Systemic: Vomiting-Mild, Additional Details: PT HAS NOT PAST MEDICAL HISTORY OF ADVERSE EVENT OR SEIZURES BUT INDICATED TO IMMUNIZER NERVOUS ABOUT VACCINE. PT  RECIEVED VACCINE AT 11:02 AM & SAT DOWN FOR MONITORING AT 11:08AM. PT HAD HEAD DOWN & STATED FEELING NAUSEOUS. WATER WAS PROVIDED BUT PT DID NOT CONSUME & WAS NOT RESPONDING TO STAFF. CONFIRMED VIA VIDEO 11:12AM PT JERKED FORWARD & FELL OVER ON HER SIDE. 911 WAS CALLED PT WAS AWAKE BUT NOT ALERT.
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Amnesia, Dizziness, Electrocardiogram normal, Fall, Fatigue
Clinical narrative: Systemic: Fainting / Unresponsive-Severe, Systemic: Flushed / Sweating-Medium, Systemic: Hypotension-Medium, Additional Details: This NP was called to pharmacy waiting area after a pt reportedly passed out after a vaccine. Upon arrival at PT's side BP was 102/52 with a pulse of 52, Pt was alert but minimally verbal and would not clearly answer questions, EMS activated. No cervical tenderness noted, no seizure-like activity present, unsure of head strike. Pt was diaphoretic and lying supine, BP 2 min after arrival was 92/60 with a HR of 68. PT was intermittently bradycardic. Transported to Hospital by EMS.
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Gait disturbance, Head injury, Headache, Illness, Loss of consciousness
Clinical narrative: Systemic: Fainting / Unresponsive-Severe, Systemic: Flushed / Sweating-Medium, Systemic: Hypotension-Medium, Additional Details: This NP was called to pharmacy waiting area after a pt reportedly passed out after a vaccine. Upon arrival at PT's side BP was 102/52 with a pulse of 52, Pt was alert but minimally verbal and would not clearly answer questions, EMS activated. No cervical tenderness noted, no seizure-like activity present, unsure of head strike. Pt was diaphoretic and lying supine, BP 2 min after arrival was 92/60 with a HR of 68. PT was intermittently bradycardic. Transported to Hospital by EMS.
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Malaise, Nausea, Somnolence, Vomiting
Clinical narrative: Systemic: Fainting / Unresponsive-Severe, Systemic: Flushed / Sweating-Medium, Systemic: Hypotension-Medium, Additional Details: This NP was called to pharmacy waiting area after a pt reportedly passed out after a vaccine. Upon arrival at PT's side BP was 102/52 with a pulse of 52, Pt was alert but minimally verbal and would not clearly answer questions, EMS activated. No cervical tenderness noted, no seizure-like activity present, unsure of head strike. Pt was diaphoretic and lying supine, BP 2 min after arrival was 92/60 with a HR of 68. PT was intermittently bradycardic. Transported to Hospital by EMS.